Acadian Asset Management LLC Immunic, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.14 - $1.53 $364,051 - $488,594	-319,343 Reduced 57.1%	239,962 $316,000
Q4 2023 Feb 13, 2024	SELL	$0.97 - $1.6 $192,006 - $316,712	-197,945 Reduced 26.14%	559,305 $837,000
Q3 2023 Nov 13, 2023	BUY	$1.35 - $2.87 $215,963 - $459,122	159,973 Added 26.78%	757,250 $1.11 Million
Q2 2023 Aug 07, 2023	BUY	$1.33 - $2.51 $647,048 - $1.22 Million	486,503 Added 439.19%	597,277 $1.5 Million
Q1 2023 May 11, 2023	SELL	$1.35 - $2.87 $45,770 - $97,304	-33,904 Reduced 23.43%	110,774 $164,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $10.8 $123,251 - $1.18 Million	109,072 Added 306.33%	144,678 $201,000
Q3 2022 Nov 14, 2022	SELL	$3.0 - $5.49 $126,402 - $231,315	-42,134 Reduced 54.2%	35,606 $112,000
Q2 2022 Aug 09, 2022	BUY	$3.13 - $12.25 $243,326 - $952,315	77,740 New	77,740 $270,000

56M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.